Markus Vähä-Koskela

7PUBLICATIONS
63CO-AUTHORS
HaematologyMolecular targetsPharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 18, 2026
Distinct stem cell identities converge into shared erythroid stress in ERCC6L2 disease and Shwachman-Diamond syndrome.

|May 12, 2025
A Machine Learning-Based Strategy Predicts Selective and Synergistic Drug Combinations for Relapsed Acute Myeloid Leukemia.

Yingjia Chen, Liye He, Aleksandr Ianevski

|Mar 19, 2025
Computational drug repurposing: approaches, evaluation of in silico resources and case studies.

Ziaurrehman Tanoli, Adrià Fernández-Torras, Umut Onur Özcan

|Jan 10, 2024
Monosomy 7/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemia.

Samuli Eldfors, Joseph Saad, Nemo Ikonen

|Dec 12, 2022
Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia.

Heikki Kuusanmäki, Olli Dufva, Markus Vähä-Koskela

|Feb 15, 2022
Pancreatic Cancer Organoids in the Field of Precision Medicine: A Review of Literature and Experience on Drug Sensitivity Testing with Multiple Readouts and Synergy Scoring.

Lotta Mäkinen, Markus Vähä-Koskela, Matilda Juusola

Pageof 2

Frequent Collaborators

4 joint publications

Caroline A Heckman

4 joint publications

Mika Kontro

4 joint publications

Kimmo Porkka

3 joint publications

Aleksandr Ianevski